1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Carl Zeiss Meditec AG
  6. Summary
    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
Real-time Estimate Tradegate  -  03:40 2022-07-05 am EDT
114.75 EUR   +1.86%
06/27CARL ZEISS MEDITEC AG : Gets a Buy rating from Deutsche Bank
MD
05/20Computer chip giant ASML places big bets on a tiny future
RE
05/16CARL ZEISS MEDITEC AG : Gets a Buy rating from Deutsche Bank
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/29/2022 06/30/2022 07/01/2022 07/04/2022 07/05/2022 Date
112.8(c) 113.9(c) 115.75(c) 112.65(c) 114.85 Last
100 527 109 547 67 330 47 820 1 940 Volume
-1.40% +0.98% +1.62% -2.68% +1.95% Change
More quotes
Estimated financial data (e)
Sales 2022 1 830 M 1 908 M 1 908 M
Net income 2022 259 M 270 M 270 M
Net cash position 2022 807 M 841 M 841 M
P/E ratio 2022 39,0x
Yield 2022 0,91%
Sales 2023 1 985 M 2 070 M 2 070 M
Net income 2023 292 M 305 M 305 M
Net cash position 2023 987 M 1 029 M 1 029 M
P/E ratio 2023 34,6x
Yield 2023 0,96%
Capitalization 10 075 M 10 507 M 10 507 M
EV / Sales 2022 5,07x
EV / Sales 2023 4,58x
Nbr of Employees 3 752
Free-Float 40,9%
More Financials
Company
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology,... 
More about the company
Ratings of Carl Zeiss Meditec AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about CARL ZEISS MEDITEC AG
06/27CARL ZEISS MEDITEC AG : Gets a Buy rating from Deutsche Bank
MD
05/20Computer chip giant ASML places big bets on a tiny future
RE
05/16CARL ZEISS MEDITEC AG : Gets a Buy rating from Deutsche Bank
MD
05/16CARL ZEISS MEDITEC AG : Buy rating from UBS
MD
05/13CARL ZEISS MEDITEC AG : DZ Bank maintains a Buy rating
MD
05/13GLOBAL MARKETS LIVE : Nissan, Toshiba, Adecco, Twitter, Robinhood...
05/13TRANSCRIPT : Carl Zeiss Meditec AG, H1 2022 Earnings Call, May 13, 2022
CI
05/13Carl Zeiss Meditec achieves further significant growth in revenue and order intake in f..
EQ
05/13Carl Zeiss Meditec AG Reaffirms Earning Guidance for 2022
CI
04/21CARL ZEISS MEDITEC AG : Hauck & Aufhauser reaffirms its Buy rating
MD
04/20CARL ZEISS MEDITEC : ZEISS Announces U.S. FDA Clearance of the QUATERA 700
PU
04/19Germany's Carl Zeiss Meditec Buys Two US-based Surgical Instrument Manufacturers
MT
04/19Carl Zeiss Meditec acquires two manufacturers of surgical instruments
EQ
04/19CARL ZEISS MEDITEC AG : Deutsche Bank remains its Buy rating
MD
04/19Carl Zeiss Meditec AG acquired Kogent Surgical, LLC and Katalyst Surgical, LLC.
CI
More news
News in other languages on CARL ZEISS MEDITEC AG
06/15AKTIEN FRANKFURT : Nächster Erholungsversuch erfolgreich - EZB beruhigt
06/15AKTIEN FRANKFURT : Nächster Erholungsversuch gelingt bislang - EZB will beruhigen
06/15AKTIEN IM FOKUS : Ausblick von Getinge belastet Medizintechnik-Branche
06/15MÄRKTE EUROPA/Alles wartet auf Fed - Große Zinserhöhung erwartet
06/09Heidelberger Druck will Kostensteigerungen mit höheren Preisen trotzen
More news
Analyst Recommendations on CARL ZEISS MEDITEC AG
More recommendations
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 112,65 €
Average target price 150,45 €
Spread / Average Target 33,6%
EPS Revisions
Managers and Directors
Markus Weber Chief Executive Officer
Justus Felix Wehmer Chief Financial Officer
Karl Lamprecht Chairman-Supervisory Board
Christian Müller Member-Supervisory Board
Cornelia Grandy Member-Supervisory Board
Sector and Competitors